Salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancer

Purpose The treatment of recurrent thyroid cancer with critical organ invasion is challenging. The combination of radiofrequency ablation (RFA) and external beam radiation therapy (EBRT) has been proposed as an effective option. This study evaluates outcomes for inoperable residual/recurrent differe...

Full description

Saved in:
Bibliographic Details
Main Authors: Chung-Shih Chen, Sheng-Dean Luo, Yen-Hsiang Chang, Chen Kai Chou, Shun-Yu Chi, Shao-Chun Wu, Yen-Hao Chen, Johnson Chia-Shen Yang, Eng-Yen Huang, Yu-Ming Wang, Wei-Che Lin
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:International Journal of Hyperthermia
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/02656736.2024.2358054
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841560891610365952
author Chung-Shih Chen
Sheng-Dean Luo
Yen-Hsiang Chang
Chen Kai Chou
Shun-Yu Chi
Shao-Chun Wu
Yen-Hao Chen
Johnson Chia-Shen Yang
Eng-Yen Huang
Yu-Ming Wang
Wei-Che Lin
author_facet Chung-Shih Chen
Sheng-Dean Luo
Yen-Hsiang Chang
Chen Kai Chou
Shun-Yu Chi
Shao-Chun Wu
Yen-Hao Chen
Johnson Chia-Shen Yang
Eng-Yen Huang
Yu-Ming Wang
Wei-Che Lin
author_sort Chung-Shih Chen
collection DOAJ
description Purpose The treatment of recurrent thyroid cancer with critical organ invasion is challenging. The combination of radiofrequency ablation (RFA) and external beam radiation therapy (EBRT) has been proposed as an effective option. This study evaluates outcomes for inoperable residual/recurrent differentiated thyroid cancer (rDTC) patients treated with RFA followed by EBRT.Materials and Methods Patients with rDTC treated with RFA followed by EBRT were retrospectively studied. RFA was performed using a free‐hand, ‘moving‐shot’ technique under US or CT guidance. For lesions invading critical structures intolerant to ‘en bloc’ high-temperature RFA, limited-field EBRT using 6‐ or 10‐MV photons was used for adjuvant treatment at a dose of 66 Gy in 33 daily fractions. Toxicities and outcomes were reviewed.Results Between April 2020 and January 2022, 11 patients with 14 rDTC lesions underwent RFA followed by EBRT. Five patients had metastatic lesions at rDTC diagnosis. With a median follow-up period of 33.7 months, all patients maintained locoregional control, while achieving a 2-year survival rate of 90.9%. This combined treatment achieved a volume reduction ratio of 92.1% ± 5.1%. The mean nadir thyroglobulin level in patients without initial distant metastases after treatment was 1.40 ± 0.81 ng/ml. Regarding treatment-related complications, one patient (9%) experienced temporary hoarseness after RFA, grade 2 radiation dermatitis occurred in 3 patients (27.2%), and grade 2 dysphagia was noted in 4 patients (36.4%). No grade 3 or greater toxicities occurred.Conclusions Salvage RFA followed by EBRT is feasible, effective and safe for patients with rDTC.
format Article
id doaj-art-54e4098e9a6644d9b871a03e2a08e16b
institution Kabale University
issn 0265-6736
1464-5157
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series International Journal of Hyperthermia
spelling doaj-art-54e4098e9a6644d9b871a03e2a08e16b2025-01-03T09:30:27ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572024-12-0141110.1080/02656736.2024.2358054Salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancerChung-Shih Chen0Sheng-Dean Luo1Yen-Hsiang Chang2Chen Kai Chou3Shun-Yu Chi4Shao-Chun Wu5Yen-Hao Chen6Johnson Chia-Shen Yang7Eng-Yen Huang8Yu-Ming Wang9Wei-Che Lin10Department of Radiation Oncology & Proton and Radiation Therapy Center, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, TaiwanDepartment of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, TaiwanDepartment of Nuclear Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, TaiwanDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, TaiwanDivision of General Surgery, Department of Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, TaiwanDepartment of Anesthesiology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, TaiwanDivision of Hemotology-Oncology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, TaiwanDivision of Plastic and Reconstructive Surgery, Department of Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, TaiwanDepartment of Radiation Oncology & Proton and Radiation Therapy Center, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, TaiwanDepartment of Radiation Oncology & Proton and Radiation Therapy Center, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, TaiwanSchool of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, TaiwanPurpose The treatment of recurrent thyroid cancer with critical organ invasion is challenging. The combination of radiofrequency ablation (RFA) and external beam radiation therapy (EBRT) has been proposed as an effective option. This study evaluates outcomes for inoperable residual/recurrent differentiated thyroid cancer (rDTC) patients treated with RFA followed by EBRT.Materials and Methods Patients with rDTC treated with RFA followed by EBRT were retrospectively studied. RFA was performed using a free‐hand, ‘moving‐shot’ technique under US or CT guidance. For lesions invading critical structures intolerant to ‘en bloc’ high-temperature RFA, limited-field EBRT using 6‐ or 10‐MV photons was used for adjuvant treatment at a dose of 66 Gy in 33 daily fractions. Toxicities and outcomes were reviewed.Results Between April 2020 and January 2022, 11 patients with 14 rDTC lesions underwent RFA followed by EBRT. Five patients had metastatic lesions at rDTC diagnosis. With a median follow-up period of 33.7 months, all patients maintained locoregional control, while achieving a 2-year survival rate of 90.9%. This combined treatment achieved a volume reduction ratio of 92.1% ± 5.1%. The mean nadir thyroglobulin level in patients without initial distant metastases after treatment was 1.40 ± 0.81 ng/ml. Regarding treatment-related complications, one patient (9%) experienced temporary hoarseness after RFA, grade 2 radiation dermatitis occurred in 3 patients (27.2%), and grade 2 dysphagia was noted in 4 patients (36.4%). No grade 3 or greater toxicities occurred.Conclusions Salvage RFA followed by EBRT is feasible, effective and safe for patients with rDTC.https://www.tandfonline.com/doi/10.1080/02656736.2024.2358054Differentiated thyroid cancerradiofrequency ablationradiotherapycombination therapyinoperablerecurrence
spellingShingle Chung-Shih Chen
Sheng-Dean Luo
Yen-Hsiang Chang
Chen Kai Chou
Shun-Yu Chi
Shao-Chun Wu
Yen-Hao Chen
Johnson Chia-Shen Yang
Eng-Yen Huang
Yu-Ming Wang
Wei-Che Lin
Salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancer
International Journal of Hyperthermia
Differentiated thyroid cancer
radiofrequency ablation
radiotherapy
combination therapy
inoperable
recurrence
title Salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancer
title_full Salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancer
title_fullStr Salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancer
title_full_unstemmed Salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancer
title_short Salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancer
title_sort salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancer
topic Differentiated thyroid cancer
radiofrequency ablation
radiotherapy
combination therapy
inoperable
recurrence
url https://www.tandfonline.com/doi/10.1080/02656736.2024.2358054
work_keys_str_mv AT chungshihchen salvageradiofrequencyablationfollowedbyexternalbeamradiotherapyforinoperablerecurrentdifferentiatedthyroidcancer
AT shengdeanluo salvageradiofrequencyablationfollowedbyexternalbeamradiotherapyforinoperablerecurrentdifferentiatedthyroidcancer
AT yenhsiangchang salvageradiofrequencyablationfollowedbyexternalbeamradiotherapyforinoperablerecurrentdifferentiatedthyroidcancer
AT chenkaichou salvageradiofrequencyablationfollowedbyexternalbeamradiotherapyforinoperablerecurrentdifferentiatedthyroidcancer
AT shunyuchi salvageradiofrequencyablationfollowedbyexternalbeamradiotherapyforinoperablerecurrentdifferentiatedthyroidcancer
AT shaochunwu salvageradiofrequencyablationfollowedbyexternalbeamradiotherapyforinoperablerecurrentdifferentiatedthyroidcancer
AT yenhaochen salvageradiofrequencyablationfollowedbyexternalbeamradiotherapyforinoperablerecurrentdifferentiatedthyroidcancer
AT johnsonchiashenyang salvageradiofrequencyablationfollowedbyexternalbeamradiotherapyforinoperablerecurrentdifferentiatedthyroidcancer
AT engyenhuang salvageradiofrequencyablationfollowedbyexternalbeamradiotherapyforinoperablerecurrentdifferentiatedthyroidcancer
AT yumingwang salvageradiofrequencyablationfollowedbyexternalbeamradiotherapyforinoperablerecurrentdifferentiatedthyroidcancer
AT weichelin salvageradiofrequencyablationfollowedbyexternalbeamradiotherapyforinoperablerecurrentdifferentiatedthyroidcancer